ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 184

Are Physician Gender, Age and Clinical Experience Associated With Discrepancy In Global Disease Score In Rheumatoid Arthritis, Ankylosing  Spondylitis and Psoriatic Arthritis? Data From The Nationwide Danbio Registry

Cecilie Lindstrom Egholm1, Niels Steen Krogh2, Lene Dreyer3, Torkell Ellingsen4, Bente Glintborg5, Marcin Kowalski6, Tove Lorenzen7, Ole Rintek Madsen8, Henrik Nordin9,10, Claus Rasmussen11 and Merete L. Hetland12, 1Regional Research Unit, Region Zealand, Roskilde, Denmark, 2ZiteLab ApS, Copenhagen, Denmark, 3Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, 4Department of Internal Medicine, Diagnostic Centre Region Hospital Silkeborg Denmark, 8600 Silkeborg, Denmark, 5Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, 6Aalborg University Hospital, Aalborg, Denmark, 7Department of Rheumatology, Region Hospital Silkeborg, Silkeborg, Denmark, 8Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, 9Department of Infectious Diseases and Rheumatology, Rigshospitalet, Copenhagen, Denmark, 10DANBIO, On behalf of Depts of Rheumatology, North, South, Central, Zealand and Capital Region, Copenhagen, Denmark, 11Vendsyssel Teaching Hospital/Aalborg University, Hjoerring, Denmark, 12Copenhagen University Hospital Glostrup, Copenhagen, Denmark

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), patient-reported outcome measures, physician data, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care-Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: A global estimate on a 100 mm Visual Analogue Scale (VAS) assessed by patients (PATGL) and physicians (DOCGL) is commonly used to measure disease activity and to monitor treatment response in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Several studies in RA have shown that PATGL and DOCGL are discordant (>20 mm difference) in about 1/3 of the encounters and have mainly focused on whether clinical measures and patient characteristics explain this. The influence of physician characteristics has not yet been examined across different arthritis diagnoses. Studies in other clinical areas suggest that treatment decisions are affected by physician gender and clinical experience. The aim of the study was therefore to assess whether physician characteristics are associated with discordance between DOCGL and PATGL in patients with RA, AS and PSA.

Methods: Physician characteristics were collected by a questionnaire sent to DANBIO physicians (n = 265). Patient characteristics and clinical measures as well as PATGL and DOCGL scores were obtained from DANBIO first encounters. A difference between DOCGL and PATGL of up to 20 mm was considered concordant, yielding three groups: PATGL>DOCGL, PATGL=DOCGL and DOCGL>PATGL. The two latter groups were merged due to few patients in DOCGL>PATGL. We used mixed effects logistic regression analyses with discordance (yes/no) as the dependent variable, performing independent analyses for each diagnosis. The model was adjusted for patient and clinical variables (e.g. age, gender, disease activity, treatment, disease duration), which were entered as covariates.

Results: 90 physicians (44% females, 61% rheumatologists, median age 52 years) returned the questionnaire (34%) and were pairwise matched with 7,619 RA, 1,291 PsA and 469 AS first encounters.

Discordance was independent of physician’s gender and age, both for patients with RA, and for patients with AS or PSA, see table. Less experienced physicians (i.e. not yet specialized) had lower odds of discordance 0.69-0.92, although it only reached statistical significance in patients with RA, see table.

Table. Mixed effects logistic regression of predictors of discordance between patient and physician assessments of global disease activity.

 

RA (N: 7,619 encounters)

AS (N: 469 encounters)

PsA (N: 1,291 encounters)

Adjusted OR  ( 95% CI)  

P

Adjusted OR  ( 95% CI)

p

Adjusted OR  ( 95% CI)

p

Physician gender, male (female=1.0)

0.83 (0.69-1.01)

NS

1.25 (0.70-2.26)

NS

1.04 (0.73-1.49)

NS

Physician age >52 years (≤52 =1.0)

1.10 (0.89-1.37)

NS

1.16 (0.59-2.30)

NS

1.17 (0.79-1.74)

NS

Rheumatologist (specialized), no (yes=1.0)

0.72 (0.55-0.93)

*

0.69 (0.31-1.52)

NS

0.92 (0.56-1.51)

NS

Concordant group is reference group.

The model was adjusted for swollen and tender joint counts (0-28), C-reactive Protein, disease duration (years), biological treatment (yes/no), country of medical exam, and doctor’s subjective rating of factors important for DOCGL (inflammation, fibromyalgia, structural joint damage, comorbidity and social factors). To account for clustering by physician and patient, these variables were included in the model as random effects.

***=p<0.001, **=p<0.01, *=p<0.05, NS=not significant

Conclusion:

: Data from clinical practice covering >9,000 DANBIO first encounters between 90 physicians and their patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis showed that, regardless of diagnosis, discordance (i.e. difference between patient’s and doctor’s global scores >20 mm) was independent of physician’s age and gender. This is reassuring for the monitoring of patients in routine care. Having specialized in rheumatology seemed to be associated with increased odds of discrepancy compared to less experienced colleagues.


Disclosure:

C. L. Egholm,
None;

N. S. Krogh,
None;

L. Dreyer,
None;

T. Ellingsen,
None;

B. Glintborg,
None;

M. Kowalski,

Abbvie,

6;

T. Lorenzen,

Phizer, Roche,

6;

O. R. Madsen,
None;

H. Nordin,
None;

C. Rasmussen,
None;

M. L. Hetland,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-physician-gender-age-and-clinical-experience-associated-with-discrepancy-in-global-disease-score-in-rheumatoid-arthritis-ankylosing-spondylitis-and-psoriatic-arthritis-data-from-the-natio/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology